We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Systematic review evaluates botulinum toxin’s effectiveness for treating allergic rhinitis, suggesting potential benefits.
BTX-A shows promise as an adjunctive therapy for refractory allergic rhinitis.
No takes yet. Share an insight, caveat, or question.
Wee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: